Guerber Lucile, Pangou Evanthia, Sumara Izabela
Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Illkirch, France.
Centre National de la Recherche Scientifique UMR 7104, Strasbourg, France.
Front Cell Dev Biol. 2022 Jun 20;10:931115. doi: 10.3389/fcell.2022.931115. eCollection 2022.
Ubiquitin Binding Protein 2-like (UBAP2L, also known as NICE-4) is a ubiquitin- and RNA-binding protein, highly conserved in metazoans. Despite its abundance, its functions have only recently started to be characterized. Several studies have demonstrated the crucial involvement of UBAP2L in various cellular processes such as cell cycle regulation, stem cell activity and stress-response signaling. In addition, UBAP2L has recently emerged as a master regulator of growth and proliferation in several human cancers, where it is suggested to display oncogenic properties. Given that this versatile protein is involved in the regulation of multiple and distinct cellular pathways, actively contributing to the maintenance of cell homeostasis and survival, UBAP2L might represent a good candidate for future therapeutic studies. In this review, we discuss the current knowledge and latest advances on elucidating UBAP2L cellular functions, with an aim to highlight the importance of targeting UBAP2L for future therapies.
泛素结合蛋白2样蛋白(UBAP2L,也称为NICE-4)是一种泛素和RNA结合蛋白,在后生动物中高度保守。尽管其含量丰富,但其功能直到最近才开始得到表征。多项研究表明,UBAP2L在细胞周期调控、干细胞活性和应激反应信号传导等各种细胞过程中起着关键作用。此外,UBAP2L最近已成为几种人类癌症中生长和增殖的主要调节因子,有人认为它具有致癌特性。鉴于这种多功能蛋白参与多种不同的细胞途径的调节,积极促进细胞稳态和存活的维持,UBAP2L可能是未来治疗研究的一个良好候选对象。在这篇综述中,我们讨论了目前关于阐明UBAP2L细胞功能的知识和最新进展,旨在强调将UBAP2L作为未来治疗靶点的重要性。